Molina Healthcare (NYSE:MOH) has been analyzed by 13 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target is $368.69, down 3.46% from the previous $381.92. Analysts have adjusted their ratings and price targets in response to market conditions. Molina Healthcare has shown a positive revenue growth rate of 18.65% as of June 2024, but faces challenges with a net margin of 3.05%. The company has a strong ROE of 6.45% and a conservative debt-to-equity ratio of 0.49.